Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
T-cell receptors (TCRs) recognizing Blomia tropicalis allergen-derived epitopes are specialized heterodimeric surface proteins on T lymphocytes that play a pivotal role in the development of allergic sensitization to the tropical house dust mite. These receptors specifically bind to immunodominant epitopes from allergens such as Blo t 5, Blo t 7, and Blo t 21, which are presented by Major Histocompatibility Complex (MHC) class II molecules on antigen-presenting cells (APCs) [PMID: 25617545]. This recognition event is the primary trigger for the activation and differentiation of allergen-specific CD4+ T cells into a Th2 phenotype, leading to the production of IgE antibodies and the recruitment of inflammatory cells like eosinophils and mast cells [PMID: 30639434]. Consequently, these TCRs are central to the pathophysiology of allergic asthma and rhinitis in tropical and subtropical climates where Blomia tropicalis is prevalent. Therapeutic interventions, such as allergen-specific immunotherapy (AIT), target these TCR-mediated pathways to induce immune tolerance [PMID: 28213450]. By modulating TCR signaling through chronic exposure to low doses of allergen, AIT promotes the expansion of regulatory T cells (Tregs) and the production of IL-10, effectively dampening the allergic cascade.
Induction of immune tolerance through T-cell anergy, deletion, or immune deviation from a Th2 to a Th1/Treg profile upon repeated exposure to allergen epitopes.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on T-cell receptor recognizing Blomia tropicalis allergen-derived epitopes (TCR (Bt-specific)).